CVAC logo

CureVac N.V. (CVAC) Cash and cash equivalents

annual cash & cash equivalents:

$501.29M+$56.42M(+12.68%)
December 31, 2024

Summary

  • As of today (July 27, 2025), CVAC annual cash & cash equivalents is $501.29 million, with the most recent change of +$56.42 million (+12.68%) on December 31, 2024.
  • During the last 3 years, CVAC annual cash & cash equivalents has fallen by -$417.46 million (-45.44%).
  • CVAC annual cash & cash equivalents is now -69.18% below its all-time high of $1.63 billion, reached on December 31, 2020.

Performance

CVAC Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACbalance sheet metrics

quarterly cash & cash equivalents:

$474.42M-$26.87M(-5.36%)
March 1, 2025

Summary

  • As of today (July 27, 2025), CVAC quarterly cash & cash equivalents is $474.42 million, with the most recent change of -$26.87 million (-5.36%) on March 1, 2025.
  • Over the past year, CVAC quarterly cash & cash equivalents has increased by +$150.28 million (+46.36%).
  • CVAC quarterly cash & cash equivalents is now -70.84% below its all-time high of $1.63 billion, reached on December 31, 2020.

Performance

CVAC quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CVAC Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.7%+46.4%
3 y3 years-45.4%-35.4%
5 y5 years+1358.5%+889.4%

CVAC Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.4%+12.7%-29.6%+118.5%
5 y5-year-69.2%+1358.5%-70.8%+118.5%
alltimeall time-69.2%+1949.7%-70.8%+1280.3%

CVAC Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$474.42M(-5.4%)
Dec 2024
$501.29M(+12.7%)
$501.29M(-18.5%)
Sep 2024
-
$615.26M(+183.4%)
Jun 2024
-
$217.08M(-33.0%)
Mar 2024
-
$324.13M(-27.1%)
Dec 2023
$444.87M(-16.3%)
$444.87M(-9.4%)
Sep 2023
-
$491.30M(-16.0%)
Jun 2023
-
$584.58M(-13.2%)
Mar 2023
-
$673.37M(+26.6%)
Dec 2022
$531.69M
$531.69M(+0.0%)
DateAnnualQuarterly
Sep 2022
-
$531.61M(-11.3%)
Jun 2022
-
$599.14M(-18.4%)
Mar 2022
-
$734.63M(-20.0%)
Dec 2021
$918.76M(-43.5%)
$918.76M(-25.3%)
Sep 2021
-
$1.23B(-23.7%)
Jun 2021
-
$1.61B(-0.8%)
Dec 2020
$1.63B(+4632.8%)
$1.63B(+55.3%)
Sep 2020
-
$1.05B(+2085.1%)
Mar 2020
-
$47.95M(+39.5%)
Dec 2019
$34.37M(+40.5%)
$34.37M
Dec 2018
$24.46M
-

FAQ

  • What is CureVac N.V. annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for CureVac N.V.?
  • What is CureVac N.V. annual cash & cash equivalents year-on-year change?
  • What is CureVac N.V. quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for CureVac N.V.?
  • What is CureVac N.V. quarterly cash & cash equivalents year-on-year change?

What is CureVac N.V. annual cash & cash equivalents?

The current annual cash & cash equivalents of CVAC is $501.29M

What is the all time high annual cash & cash equivalents for CureVac N.V.?

CureVac N.V. all-time high annual cash & cash equivalents is $1.63B

What is CureVac N.V. annual cash & cash equivalents year-on-year change?

Over the past year, CVAC annual cash & cash equivalents has changed by +$56.42M (+12.68%)

What is CureVac N.V. quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of CVAC is $474.42M

What is the all time high quarterly cash & cash equivalents for CureVac N.V.?

CureVac N.V. all-time high quarterly cash & cash equivalents is $1.63B

What is CureVac N.V. quarterly cash & cash equivalents year-on-year change?

Over the past year, CVAC quarterly cash & cash equivalents has changed by +$150.28M (+46.36%)
On this page